memantine hydrochloride and donepezil hydrochloride
memantine hydrochloride and donepezil hydrochloride is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand names including memantine hydrochloride and donepezil hydrochloride, Namzaric. Available dosage forms: capsule, capsule, extended release.
Drug Details
- Generic Name
- memantine hydrochloride and donepezil hydrochloride
- Brand Names
- memantine hydrochloride and donepezil hydrochloride, Namzaric
- Application Number
- ANDA216901
- Sponsor
- Allergan, Inc.
- NDC Codes
- 10
- Dosage Forms
- CAPSULE, CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- MEMANTINE HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Memantine and donepezil hydrochlorides extended-release capsules is indicated for the treatment of moderate to severe dementia of the Alzheimer's type in patients stabilized on 10 mg of donepezil hydrochloride once daily. Memantine and donepezil hydrochlorides extended-release capsules is a combination of memantine hydrochloride, an NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor, indicated for the treatment of moderate to severe dementia of the Alzheimer's type in patients stabilized on 10 mg of donepezil hydrochloride once daily. ( 1 )